ARCHIVES

Kessler Promises Cancer Patient Liaison In FDA; Considers Joint Drugs, Biologics Oncology Review

This article is from The Cancer Letter archive.

Vol. 18 No. 33 | August 14, 1992

Download PDF Visit The Full Archive

Related Articles

Donald Berry To Step Down From Departmental Posts At MD Anderson

November 26, 2010

Cediranib/Olaparib Combination Nearly Doubles PFS in Phase II

September 26, 2014

Nixon to Receive ACCC Annual Award

January 10, 1986

Centers Ask Americans for $1 Each for Research.

May 16, 2008

New Mexico Program Covers Entire State

January 21, 1977

Panel Recommends 5-FU/Levamisole For Adjuvant Stage 3 Colon Cancer

April 27, 1990